Follow
Tae Yoon Lee
Title
Cited by
Cited by
Year
Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
M Sadatsafavi, J McCormack, J Petkau, LD Lynd, TY Lee, DD Sin
European Respiratory Journal 57 (2), 2021
262021
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease
AW Wong, TY Lee, KA Johannson, D Assayag, J Morisset, CD Fell, ...
Respiratory Research 21, 1-9, 2020
242020
ACCEPT 2· 0: recalibrating and externally validating the acute COPD exacerbation prediction tool (ACCEPT)
A Safari, A Adibi, DD Sin, TY Lee, JK Ho, M Sadatsafavi
EClinicalMedicine 51, 2022
92022
Value-of-Information Analysis for External Validation of Risk Prediction Models
M Sadatsafavi, TY Lee, L Wynants, AJ Vickers, P Gustafson
Medical Decision Making 43 (5), 564-575, 2023
72023
Uncertainty and the value of information in risk prediction modeling
M Sadatsafavi, T Yoon Lee, P Gustafson
Medical Decision Making 42 (5), 661-671, 2022
62022
Cost-effectiveness of budesonide-formoterol vs inhaled epinephrine in US adults with mild asthma
JK Ho, M Shaker, M Greenhawt, M Sadatsafavi, EM Abrams, ...
Annals of Allergy, Asthma & Immunology 132 (2), 229-239. e3, 2024
52024
Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada
JE Amegadzie, TY Lee, M Sadatsafavi, LD Lynd, DD Sin, KM Johnson
CMAJ 195 (35), E1172-E1179, 2023
52023
16-year trends in asthma hospital admissions in Canada
TY Lee, J Petkau, N Mangat, A Safari, JJ Cragg, LD Lynd, JM FitzGerald, ...
Annals of Allergy, Asthma & Immunology 129 (4), 475-480. e2, 2022
52022
Long-term natural history of severe asthma exacerbations and their impact on the disease course
TY Lee, J Petkau, M Sadatsafavi
Annals of the American Thoracic Society 19 (6), 907-915, 2022
52022
QRISK3 underestimates the risk of cardiovascular events in patients with COPD
JE Amegadzie, Z Gao, JK Quint, R Russell, JR Hurst, TY Lee, DD Sin, ...
thorax, 2023
42023
Dimensional analysis in statistical modelling
TY Lee, JV Zidek, N Heckman
arXiv preprint arXiv:2002.11259, 2020
32020
Closed-Form Solution of the Unit Normal Loss Integral in 2 Dimensions, with Application in Value-of-Information Analysis
TY Lee, P Gustafson, M Sadatsafavi, ...
Medical Decision Making 43 (5), 621, 2023
22023
Development of a conceptual model of childhood asthma to inform asthma prevention policies
A Adibi, SE Turvey, TY Lee, MR Sears, AB Becker, PJ Mandhane, ...
BMJ Open Respiratory Research 8 (1), e000881, 2021
22021
Smarter Parking: Using AI to Identify Parking Inefficiencies in Vancouver
D Graham, SK Sarraf, T Lundy, A MohammadMehr, S Uppal, TY Lee, ...
arXiv preprint arXiv:2003.09761, 2020
12020
International Variation in Exacerbation Rates in Patients With Severe Asthma
CP Yadav, TY Lee, DB Price, R Roy, LLH Mien, E Wang, ME Wechsler, ...
D22. ADVANCES IN HEALTH SERVICES RESEARCH IN ASTHMA, A7021-A7021, 2024
2024
Development and Validation of an Individualised Risk Prediction Model for Exacerbations in Patients With Severe Asthma in Real-world Settings
W Chen, D Price, CP Yadav, RW Beasley, C Janson, TY Lee, ...
C102. CLINICAL AND TRANSLATIONAL ADVANCES IN ASTHMA, A6700-A6700, 2024
2024
Lung function as independent predictor of cardiovascular disease risk: implications for practice and policy
TY Lee, M Sadatsafavi
Thorax 79 (3), 196-197, 2024
2024
International variation in severe exacerbation rates in patients with severe asthma
TY Lee, D Price, CP Yadav, R Roy, LLH Mien, E Wang, ME Wechsler, ...
Chest, 2024
2024
The expected value of sample information calculations for external validation of risk prediction models
M Sadatsafavi, AJ Vickers, TY Lee, P Gustafson, L Wynants
arXiv preprint arXiv:2401.01849, 2024
2024
Development and Validation of an Asthma Policy Model for Canada: Lifetime Exposures and Asthma outcomes Projection (LEAP)
TY Lee, J Petkau, KM Johnson, S Turvey, A Adibi, P Subbarao, ...
medRxiv, 2024.03. 11.24304122, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20